InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
-0.34%
)
US TECH 100
16,900.00
(
-0.49%
)
Dow Jones
37,903.29
(
0.23%
)
Brent Oil
83.55
(
-2.74%
)
Bitcoin
57,824.95
(
-4.58%
)
Post# of 2980
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Zorch305

Send PM Follow Ignore
Followers 190
Posts 17675
Boards Moderated 0
Alias Born 12/29/2006

Zorch305

Member Level

Re: None

Tuesday, 05/15/2018 6:56:20 AM

Tuesday, May 15, 2018 6:56:20 AM

Post# of 2980
According to Genome Web, the deal between the two companies is worth $14 million — $7 million in cash and $7 million in stock. For the stock portion, Cancer Genetics will issue 788,584 shares of its common stock to Response Genetics.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM

Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM

Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM

Start posting your company's news
Only $200 per official company press release!